Phytochemicals in Alzheimer disease, the development of clinical trials

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · see citing works

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works

Inflammation and Alzheimer’s disease

Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514 · see citing works

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · see citing works

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · see citing works

Diffusible, nonfibrillar ligands derived from Aβ _1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · see citing works

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · see citing works

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

Perry, E., Tomlinson, B. E., Blessed, G., Bergmann, K., Gibson, P., & Perry, R. H. (1978) · British medical journal · doi:10.1136/bmj.2.6150.1457 · Cited by 2,043 · see citing works

The Curry Spice Curcumin Reduces Oxidative Damage and Amyloid Pathology in an Alzheimer Transgenic Mouse

Lim, G. P., Chu, T., Yang, F., Beech, W., Frautschy, S. A., & Cole, G. M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-21-08370.2001 · Cited by 1,530 · see citing works

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404 · see citing works

Increase in Circulating Products of Lipid Peroxidation (F2-Isoprostanes) in Smokers — Smoking as a Cause of Oxidative Damage

Morrow, J. D., Frei, B. B., Longmire, A. W., Gaziano, J. M., Lynch, S. M., Shyr, Y., Strauss, W., Oates, J. A., & Roberts, L. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505043321804 · Cited by 1,340 · see citing works

A Placebo-Controlled, Double-blind, Randomized Trial of an Extract of Ginkgo Biloba for Dementia

Le Bars, P. L. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550160047037 · Cited by 966 · see citing works

Localization of Neurofibrillary Tangles and Beta-Amyloid Plaques in the Brains of Living Patients With Alzheimer Disease

Shoghi, K. I., Small, G. W., Agdeppa, E. D., Kepe, V., Ercoli, L. M., Siddarth, P., Read, S., Satyamurthy, N., Petrič, A., Huang, S., et al. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200201000-00004 · Cited by 774 · see citing works

APPSW Transgenic Mice Develop Age-related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1

IRIZARRY, M. C., MCNAMARA, M., FEDORCHAK, K., HSIAO, K., & HYMAN, B. T. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199709000-00002 · Cited by 649 · see citing works

Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia

Jack, C. R., Dickson, D. W., Parisi, J. E., Xu, Y. C., Cha, R. H., O’Brien, P. C., Edland, S. D., Smith, G. E., Boeve, B. F., Tangalos, E. G., et al. (2002) · Neurology · doi:10.1212/wnl.58.5.750 · Cited by 610 · see citing works

Microglial response to amyloid plaques in APPsw transgenic mice.

Frautschy, S. A., Yang, F., Irrizarry, M., Hyman, B. T., Saido, T. C., Hsiao, K., & Cole, G. M. (1998) · Europe PMC (PubMed Central) · Cited by 592 · see citing works

Increase of Brain Oxidative Stress in Mild Cognitive Impairment

Praticò, D., Clark, C. M., Liun, F., Lee, V., & Trojanowski, J. Q. (2002) · Archives of Neurology · doi:10.1001/archneur.59.6.972 · Cited by 587 · see citing works

The Efficacy of Ginkgo biloba on Cognitive Function in Alzheimer Disease

Oken, B., Storzbach, D. M., & Kaye, J. A. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1409 · Cited by 585 · see citing works

The isoprostanes: Unique bioactive products of lipid peroxidation

Morrow, J. D., & Roberts, L. J. (1997) · Progress in Lipid Research · doi:10.1016/s0163-7827(97)00001-5 · Cited by 556 · see citing works

Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

Smith, M. A., Hirai, K., Hsiao, K., Pappolla, M. A., Harris, P. L. R., Siedlak, S. L., Tabaton, M., & Perry, G. L. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052212.x · Cited by 547 · see citing works

Aging renders the brain vulnerable to amyloid β-protein neurotoxicity

Guela, C., Wu, C.-K., Saroff, D., Lorenzo, A., Yuan, M., & Yankner, B. A. (1998) · Nature Medicine · doi:10.1038/nm0798-827 · Cited by 520 · see citing works

γ-Secretase, notch, Aβ and alzheimer's disease: Where do the presenilins fit in?

Sisodia, S. S., & St George-Hyslop, P. H. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn785 · Cited by 512 · see citing works

Lipid peroxidation in aging brain and Alzheimer’s disease1,2 1Guest Editors: Mark A. Smith and George Perry 2This article is part of a series of reviews on “Causes and Consequences of Oxidative Stress in Alzheimer’s Disease.” The full list of papers may be found on the homepage of the journal.

Montine, T. J., Neely, M. D., Quinn, J. F., Beal, M. F., Markesbery, W. R., Roberts, L. J., & Morrow, J. D. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00807-9 · Cited by 449 · see citing works

Modification of Brain Aging and Neurodegenerative Disorders by Genes, Diet, and Behavior

Mattson, M. P., Chan, S. L., & Duan, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00004.2002 · Cited by 438 · see citing works

ALZHEIMER'S DISEASE: Genetic Studies and Transgenic Models

Price, D. L., Tanzi, R. E., Borchelt, D. R., & Sisodia, S. S. (1998) · Annual Review of Genetics · doi:10.1146/annurev.genet.32.1.461 · Cited by 406 · see citing works

Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia

Kaye, J. A., Swihart, T., Howieson, D., Dame, A., Moore, M. M., Karnos, T., Camicioli, R., Ball, M., Oken, B., & Sexton, G. (1997) · Neurology · doi:10.1212/wnl.48.5.1297 · Cited by 399 · see citing works

Inhibition of amyloid-β aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761

Luo, Y., Smith, J. V., Paramasivam, V., Burdick, A. J., Curry, K. J., Buford, J. P., Khan, I. A., Netzer, W. J., Xu, H., & Butko, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182425199 · Cited by 399 · see citing works

The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β‐amyloid

Bastianetto, S., Ramassamy, C., Doré, S., Christen, Y., Poirier, J., & Quirion, R. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00069.x · Cited by 378 · see citing works

Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in Japan

Kanai, M., Matsubara, E., Isoe, K., Urakami, K., Nakashima, K., Arai, H., Sasaki, H., Abe, K., Iwatsubo, T., Kosaka, T., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410440108 · Cited by 340 · see citing works

Correlation between rates of brain atrophy and cognitive decline in AD

Fox, N. C., Scahill, R. I., Crum, W. R., & Rossor, M. N. (1999) · Neurology · doi:10.1212/wnl.52.8.1687 · Cited by 338 · see citing works

Evidence for glial-mediated inflammation in aged APPSW transgenic mice

Benzing, W. C., Wujek, J. R., Ward, E. K., Shaffer, D. J., Ashe, K. H., Younkin, S. G., & Brunden, K. R. (1999) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00065-2 · Cited by 298 · see citing works

Changes in premorbid brain volume predict Alzheimer’s disease pathology

Silbert, L. C., Quinn, J. F., Moore, M. M., Corbridge, E., Ball, M. J., MURDOCH, G. H., Sexton, G. J., & Kaye, J. A. (2003) · Neurology · doi:10.1212/01.wnl.0000079053.77227.14 · Cited by 280 · see citing works

MRI of the Hippocampus in Alzheimer’s Disease: Sensitivity, Specificity, and Analysis of the Incorrectly Classified Subjects

Laakso, M. P., Soininen, H. S., Partanen, K. P. L., Lehtovirta, M., Hallikainen, M., Hänninen, T., Helkala, E.-L., Vainio, P. A., & Riekkinen, P. J. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00006-2 · Cited by 265 · see citing works

Increased CSF F 2 -isoprostane concentration in probable AD

Montine, T. J., Beal, M. F., Cudkowicz, M., O’Donnell, H., Margolin, R. A., McFarland, L. L., Bachrach, A., Zackert, W. E., Roberts, L. J., & Morrow, J. D. (1999) · Neurology · doi:10.1212/wnl.52.3.562 · Cited by 251 · see citing works

Amyloid β protein 1–40 and 1–42 levels in matched cerebrospinal fluid and plasma from patients with Alzheimer disease

Mehta, P. D., Pirttilä, T., Patrick, B. A., Barshatzky, M., & Mehta, S. P. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01754-2 · Cited by 230 · see citing works

Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment

Stackman, R. W., Eckenstein, F., Frei, B., Kulhanek, D., Nowlin, J., & Quinn, J. F. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00399-6 · Cited by 230 · see citing works

Fruit Polyphenolics and Brain Aging

Galli, R. L., Shukitt‐Hale, B., Youdim, K. A., & Joseph, J. A. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02089.x · Cited by 199 · see citing works

Alzheimer's Disease Assessment Scale (ADAS).

Mohs, R. C., & Cohen, L. (1988) · PubMed · Cited by 195 · see citing works

Anti-inflammatory and antioxidant activities of cat's claw (Uncaria tomentosa and Uncaria guianensis) are independent of their alkaloid content

Sandoval, M., Okuhama, N. N., Zhang, X.-J., Condezo‐Hoyos, L., Lao, J., Angeles, F. M., Musah, R. A., Bobrowski, P. J., & Miller, M. J. S. (2002) · Phytomedicine · doi:10.1078/0944-7113-00117 · Cited by 189 · see citing works

High Levels of Circulating Aβ42 Are Sequestered by Plasma Proteins in Alzheimer's Disease

Kuo, Y., Emmerling, M. R., Lampert, H. C., Hempelman, S. R., Kokjohn, T. A., Woods, A. S., Cotter, R. J., & Roher, A. E. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0552 · Cited by 182 · see citing works

The Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from β-amyloid-induced cell death by inhibiting the formation of β-amyloid-derived diffusible neurotoxic ligands

Yao, Z., Drieu, K., & Papadopoulos, V. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03131-0 · Cited by 181 · see citing works

Peripheral F2‐isoprostanes and F4‐neuroprostanes are not increased in Alzheimer's disease

Montine, T. J., Quinn, J. F., Milatović, D., Silbert, L. C., Dang, T. N. T., Sanchez, S. C., Terry, E. S., Roberts, L. J., Kaye, J. A., & Morrow, J. D. (2002) · Annals of Neurology · doi:10.1002/ana.10272 · Cited by 156 · see citing works

Amyloid β protein in plasma from patients with sporadic Alzheimer's disease

Tamaoka, A., Fukushima, T., Sawamura, N., Ishikawa, K., Oguni, E., Komatsuzaki, Y., & Shoji, S. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00143-8 · Cited by 154 · see citing works

The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected β-amyloid in the rat brain

Emre, M., Geula, C., Ransil, B., & Mesulam, M. M. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90055-3 · Cited by 125 · see citing works

Cerebrospinal Fluid Aβ42, Tau, and F2-Isoprostane Concentrations in Patients With Alzheimer Disease, Other Dementias, and in Age-Matched Controls

Montine, T. J., Kaye, J. A., Montine, K. S., McFarland, L. L., Morrow, J. D., & Quinn, J. F. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-0510-cfataf · Cited by 121 · see citing works

Transgenic mice expressing Alzheimer amyloid precursor proteins

Hsiao, K. (1998) · Experimental Gerontology · doi:10.1016/s0531-5565(98)00045-x · Cited by 119 · see citing works

The Magnitude of Brain Lipid Peroxidation Correlates with the Extent of Degeneration but Not with Density of Neuritic Plaques or Neurofibrillary Tangles or with APOE Genotype in Alzheimer's Disease Patients

Montine, T. J., Markesbery, W. R., Zackert, W. E., Sanchez, S. C., Roberts, L. J., & Morrow, J. D. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65185-1 · Cited by 116 · see citing works

β-Amyloid neurotoxicity: A discussion of in vitro findings

Cotman, C. W., Pike, C. J., & Copani, A. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90060-b · Cited by 112 · see citing works

Imaging Amyloid-β Deposits In Vivo

Bacskai, B. J., Klunk, W. E., Mathis, C. A., & Hyman, B. T. (2002) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200209000-00001 · Cited by 106 · see citing works

Neuroprotective approaches in experimental models of β-Amyloid neurotoxicity: Relevance to Alzheimer's disease

Harkany, T., Hortobágyi, T., Sasvári, M., Kónya, C., Penke, B., Luiten, P. G. M., & Nyakas, C. J. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00058-5 · Cited by 97 · see citing works

Effects of an extract of Ginkgo biloba on learning and memory in mice

Winter, E. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90597-u · Cited by 89 · see citing works

Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers.

Sjögren, M., Andreasen, N., & Blennow, K. (2003) · Clinica chimica acta; international journal of clinical chemistry · doi:10.1016/s0009-8981(03)00121-9 · Cited by 88 · see citing works

Apolipoprotein E4 promotes the early deposition of Aβ42 and then Aβ40 in the elderly

Walker, L. C., Pahnke, J., Madauss, M., Vogelgesang, S., Pahnke, A., Herbst, E. W., Stausske, D., Walther, R., Kessler, C., & Warzok, R. (2000) · Acta Neuropathologica · doi:10.1007/s004010051190 · Cited by 81 · see citing works

Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-1 and amyloid precursor protein mutant genes

Hernandez, D., Sugaya, K., Qu, T., McGowan, E., Duff, K., & McKinney, M. (2001) · Neuroreport · doi:10.1097/00001756-200105250-00018 · Cited by 73 · see citing works

Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment

de Leon, M. J., Segal, S., Tarshish, C. Y., DeSanti, S., Zinkowski, R. P., Mehta, P. D., Convit, A. J., Caraos, C., Rusinek, H., Tsui, W., et al. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01038-8 · Cited by 70 · see citing works

Micronutrients in Cancer Chemoprevention

Greenwald, P., Milner, J. A., Anderson, D. E., & McDonald, S. S. (2002) · Cancer and Metastasis Reviews · doi:10.1023/a:1021202709003 · Cited by 67 · see citing works

Effect of long-term treatment with EGb 761 on age-dependent structural changes in the hippocampi of three inbred mouse strains

Barkats, M., Venault, P., Christen, Y., & Cohen‐Salmon, C. (1994) · Life Sciences · doi:10.1016/0024-3205(94)00915-5 · Cited by 63 · see citing works

Effects ofUncaria tomentosaTotal Alkaloid and its Components on Experimental Amnesia in Mice: Elucidation Using the Passive Avoidance Test

Abdel-Fattah, M. A. F., Matsumoto, K., Tabata, K., Takayama, H., Kitajima, M., Aimi, N., & Watanabe, H. (2000) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357001777612 · Cited by 58 · see citing works

Interspecies Scaling: Predicting Oral Clearance in Humans

Mahmood, I. (2002) · American Journal of Therapeutics · doi:10.1097/00045391-200201000-00008 · Cited by 33 · see citing works

Longitudinal study of cerebrospinal fluid amyloid proteins and apolipoprotein E in patients with probable Alzheimer's disease

Pirttilä, T., Koivisto, K. J., Mehta, P. D., Reinikainen, K. J., Kim, K. S., Kilkku, O., Heinonen, E. H., Soininen, H. S., Riekkinen, P. J., & Wı́sniewski, H. M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00381-4 · Cited by 31 · see citing works

MRS in relation to hippocampal volume in the oldest old

Spencer, D. C., Zitzelberger, T., Spielman, D. M., & Kaye, J. A. (2003) · Neurology · doi:10.1212/01.wnl.0000052822.22994.86 · Cited by 13 · see citing works

Transderm-induced psychosis in Parkinson's disease

Quinn, N. P., Minagar, A., Shulman, L. M., & Weiner, W. J. (2000) · Neurology · doi:10.1212/wnl.54.9.1877 · Cited by 2 · see citing works

Indian Medicinal Herbs and Formulations for Alzheimer’s Disease, from Traditional Knowledge to Scientific Assessment

Mehla, J., Gupta, P., Pahuja, M., Diwan, D., & Diksha, D. (2020) · Brain Sciences · doi:10.3390/brainsci10120964 · Cited by 108 · see citing works

Plants with neurobiological activity as potential targets for drug discovery

Gomes, N. G. M., Campos, M. G., Órfão, J., & Ribeiro, C. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.07.033 · Cited by 99 · see citing works

Systematic Review on the Efficacy and Safety of Herbal Medicines for Alzheimer's Disease

Man, S. C., Durairajan, S. S. K., Kum, W. F., Lu, J., Huang, J. D., Cheng, C. F., Chung, V. C., Xu, M., & Li, M. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-14209 · Cited by 46 · see citing works

Potential of Horse Apple Isoflavones in Targeting Inflammation and Tau Protein Fibrillization

Abourashed, E. A., Abraha, A., Khan, S. I., McCants, T., & Awan, S. (2015) · Natural Product Communications · doi:10.1177/1934578x1501000923 · Cited by 11 · see citing works

Oral intake of carboxy alkyl ester improves attention: A randomized double‐blind cross‐over placebo‐controlled study

Guthrie, O. W., & Li, Y. (2023) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2885 · Cited by 3 · see citing works

Perspective and Direction for Future Research on Phytochemicals in Neurological Disorders

Farooqui, A. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3804-5_11 · Cited by 1 · see citing works

CSF biomarkers of AD: monitoring therapeutic targets N eurodegenerative Disease

Quinn, J. F., & Montine, T. J. (2005)

Phenols as an alternative, neuroprotective, and preventive strategy for Alzheimer's disease: (mini-review and bibliometric analysis)

Íñiguez-Luna, M. I., Suárez-Medellín, J. A., & Limón, A. M. V. (2023) · Agro Productividad · doi:10.32854/agrop.v16i9.2716

Phytochemicals as Micronutrients: What Is their Therapeutic Promise in the Management of Alzheimer’s Disease?

Reslan, M. A., Issa, H., Al-Haj, N., Ibeh, S., Yehya, Y., Hassan, H. H., Kobeissy, F. H., Eid, A. H., Zibara, K., & Shaito, A. A. (2022) · Nutritional neurosciences · doi:10.1007/978-981-16-6467-0_15 · Cited by 1 · see citing works

Phytochemicals in Alzheimer’s Disease Prevention and Management: Molecular Mechanisms, Therapeutic Potential, Translational Challenges, and Emerging Research Directions

Khan, M. S., Zafar, I., & Bopassa, J. C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146329 · Cited by 1 · see citing works

Multi‐Targeting Phytochemicals for Alzheimer's Disease

Bhattacharya, R. S., Singh, R., Panghal, A., Thakur, A., Singh, L., Verma, R. K., Singh, C., Goyal, M., & Kumar, J. (2025) · Phytotherapy Research · doi:10.1002/ptr.8435 · Cited by 17 · see citing works

Potential role of phytochemicals in attenuating Alzheimer’s disease - A comprehensive review

Ubed, M., Irfan, W., Shahid, J., Alice, M., & Faisal, E. (2025) · NUST Journal of Natural Sciences · doi:10.53992/njns.v10i4.292

Phytochemicals in the Treatment of Alzheimer's Disease: A Systematic Review

D’Onofrio, G., Sancarlo, D., Ruan, Q., Yu, Z., Panza, F., Daniele, A., Greco, A., & Seripa, D. (2016) · Current Drug Targets · doi:10.2174/1389450117666161102121553 · Cited by 59 · see citing works